PD15-01 FSH IS UNRELATED TO MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) AND MORTALITY AMONG MEN RECEIVING ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER (PC)

INTRODUCTION AND OBJECTIVES:Previous studies found men starting a LHRH-agonist (LHRH-a) are at increased risk of MACE, however this conflicts with randomized trials where no links are seen. FSH is ...